Baiyun Mountain (00874): Changes to Zhongyi Pharmaceutical's “Pharmaceutical Production License”

Zhitongcaijing · 2d ago

Zhitong Finance App News, Baiyunshan (00874) issued an announcement. Recently, Guangzhou Baiyunshan Zhongyi Pharmaceutical Co., Ltd. (hereinafter referred to as “Zhongyi Pharmaceutical”), a subsidiary of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (hereinafter referred to as “the Company”), received a “Pharmaceutical Production License” approved and issued by the Guangdong Drug Administration, agreeing to Zhongyi Pharmaceutical to change the production manager and reduce the production address, production scope, and workshop production line.

The shared traditional Chinese medicine pre-treatment and extraction workshop production line located in Qixinggang, Nancun Town, Panyu District, Guangzhou, belongs to Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd. (“Mingxing Pharmaceutical”), a subsidiary of the Company. Due to the actual production situation and resource integration needs of Mingxing Pharmaceutical, it has reduced the production address, production scope, and workshop production line. The current reduction in production address, production scope, and workshop production line by Zhongyi Pharmaceutical is in response to the needs of the company's production capacity adjustment, and will not affect the production of Zhongyi Pharmaceutical. The work of the relevant management personnel of Zhongyi Pharmaceutical was adjusted, and the person in charge of production was changed accordingly. The “Pharmaceutical Production License” was obtained this time, and there was no significant impact on the company's current performance.